Is Bio-adrenomedullin (Bio-ADM) a Prognostic Factor in Patients With COVID-19 Treated in the ICU?
Clinical trial NCT04813939 · TERMINATED
Trial details
- NCT number
- NCT04813939
- Sponsor
- Medical University of Warsaw
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2021-03-22
- Primary completion
- 2021-12-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.